AT347172B - Verfahren zur herstellung eines tierheilmittels - Google Patents

Verfahren zur herstellung eines tierheilmittels

Info

Publication number
AT347172B
AT347172B AT705973A AT705973A AT347172B AT 347172 B AT347172 B AT 347172B AT 705973 A AT705973 A AT 705973A AT 705973 A AT705973 A AT 705973A AT 347172 B AT347172 B AT 347172B
Authority
AT
Austria
Prior art keywords
manufacturing
medicinal product
animal medicinal
animal
product
Prior art date
Application number
AT705973A
Other languages
English (en)
Other versions
ATA705973A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA705973A publication Critical patent/ATA705973A/de
Application granted granted Critical
Publication of AT347172B publication Critical patent/AT347172B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
AT705973A 1972-08-14 1973-08-13 Verfahren zur herstellung eines tierheilmittels AT347172B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1200872 1972-08-14

Publications (2)

Publication Number Publication Date
ATA705973A ATA705973A (de) 1978-04-15
AT347172B true AT347172B (de) 1978-12-11

Family

ID=4378980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT705973A AT347172B (de) 1972-08-14 1973-08-13 Verfahren zur herstellung eines tierheilmittels

Country Status (10)

Country Link
JP (1) JPS594401B2 (de)
AT (1) AT347172B (de)
BE (1) BE803553A (de)
DD (1) DD109186A5 (de)
DE (1) DE2340709C2 (de)
ES (1) ES417804A1 (de)
FR (1) FR2196157B1 (de)
GB (1) GB1442625A (de)
HU (1) HU167371B (de)
NL (1) NL7311001A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
DE3722886A1 (de) * 1987-07-10 1989-01-19 Basf Ag Verfahren zur herstellung von (alpha),ss-substituierten acroleinen und neue substituierte acroleine

Also Published As

Publication number Publication date
HU167371B (de) 1975-09-27
ES417804A1 (es) 1976-06-16
DE2340709A1 (de) 1974-02-28
GB1442625A (en) 1976-07-14
NL7311001A (de) 1974-02-18
FR2196157B1 (de) 1978-07-28
DD109186A5 (de) 1974-10-20
DE2340709C2 (de) 1983-12-22
BE803553A (fr) 1974-02-13
JPS594401B2 (ja) 1984-01-30
FR2196157A1 (de) 1974-03-15
JPS49124062A (de) 1974-11-27
ATA705973A (de) 1978-04-15
AU5917673A (en) 1975-02-13

Similar Documents

Publication Publication Date Title
AT332205B (de) Verfahren zur herstellung eines fleischahnlichen proteinproduktes
AT340228B (de) Verfahren zur herstellung eines verbundgegenstandes
AT342002B (de) Verfahren zur herstellung wasserunloslicher kapseln
AT326998B (de) Verfahren zur herstellung kunststoffgefullter papiere
AT320412B (de) Verfahren zur Herstellung eines eßbaren Produktes
AT340686B (de) Verfahren zur herstellung eines polyelektrolyten
AT330360B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT329313B (de) Verfahren zur herstellung eines veterinarmedizinischen praparates
AT337902B (de) Verfahren zur herstellung eines pharmazeutischen pulvers
AT325038B (de) Verfahren zur herstellung eines optisch aktiven lactons
AT346677B (de) Verfahren zur herstellung eines koagulierten milchproduktes
ATA236973A (de) Verfahren zur herstellung von sterolinreichen produkten
DD105518A5 (de) Verfahren zur herstellung eines elektro-fotografischen filmprodukts
AT324311B (de) Verfahren zur herstellung neuer 2-nitriloalkylaminoalkanamidobenzophenone
AT330557B (de) Verfahren zur herstellung eines essbaren produktes
AT327893B (de) Verfahren zur herstellung neuer xanthoncarbonsaurederivate
AT347172B (de) Verfahren zur herstellung eines tierheilmittels
CH556859A (de) Verfahren zur herstellung eines triazolyl-naphthalimids.
AT323682B (de) Verfahren zur herstellung eines backmittels
AT358065B (de) Verfahren zur herstellung neuer anhydrofuranosederivate
CH554775A (de) Verfahren zur herstellung eines verpackungsmaterials.
AT324108B (de) Verfahren zur herstellung eines tierfuttermittels
AT326120B (de) Verfahren zur herstellung neuer isoxazolidinderivate
DD111541A5 (de) Verfahren zur herstellung eines pestizides
AT344879B (de) Verfahren zur herstellung eines pharmazeutischen kombinationspraeparates

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee